RenéS. Kahn

600 total citations
15 papers, 498 citations indexed

About

RenéS. Kahn is a scholar working on Cellular and Molecular Neuroscience, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, RenéS. Kahn has authored 15 papers receiving a total of 498 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 5 papers in Psychiatry and Mental health and 4 papers in Molecular Biology. Recurrent topics in RenéS. Kahn's work include Neurotransmitter Receptor Influence on Behavior (5 papers), Schizophrenia research and treatment (5 papers) and Stress Responses and Cortisol (3 papers). RenéS. Kahn is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (5 papers), Schizophrenia research and treatment (5 papers) and Stress Responses and Cortisol (3 papers). RenéS. Kahn collaborates with scholars based in United States and Netherlands. RenéS. Kahn's co-authors include H.G.M. Westenberg, Johan A. den Boer, Harold J.G.M. van Megen, H. M. van Praag, Scott Wetzler, Gregory M. Asnis, Seth Apter, Robert G. Stern, Farooq Amin and Demitri F. Papolos and has published in prestigious journals such as Biological Psychiatry, Journal of Affective Disorders and Psychiatry Research.

In The Last Decade

RenéS. Kahn

15 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
RenéS. Kahn United States	13	272	139	121	110	110	15	498
Bruce I. Diamond United States	14	306 1.1×	141 1.0×	221 1.8×	81 0.7×	89 0.8×	27	721
A. Hoh Germany	5	206 0.8×	89 0.6×	63 0.5×	131 1.2×	61 0.6×	5	406
Mark Fulton United States	11	210 0.8×	71 0.5×	84 0.7×	64 0.6×	61 0.6×	14	500
George N.M. Gurguis United States	15	133 0.5×	96 0.7×	109 0.9×	191 1.7×	144 1.3×	34	559
David Nutt United Kingdom	7	173 0.6×	114 0.8×	120 1.0×	43 0.4×	54 0.5×	10	541
U. W. Preuss Germany	12	226 0.8×	117 0.8×	86 0.7×	86 0.8×	33 0.3×	21	487
Murphy Dl United States	12	189 0.7×	70 0.5×	146 1.2×	45 0.4×	49 0.4×	29	490
Thomas Geiss-Granadia Austria	6	171 0.6×	80 0.6×	107 0.9×	45 0.4×	77 0.7×	7	434
D. Hommer United States	6	627 2.3×	202 1.5×	140 1.2×	74 0.7×	110 1.0×	11	929
Patrick Papart Belgium	14	124 0.5×	54 0.4×	116 1.0×	85 0.8×	117 1.1×	34	487

Countries citing papers authored by RenéS. Kahn

Since Specialization

Citations

This map shows the geographic impact of RenéS. Kahn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RenéS. Kahn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RenéS. Kahn more than expected).

Fields of papers citing papers by RenéS. Kahn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RenéS. Kahn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RenéS. Kahn. The network helps show where RenéS. Kahn may publish in the future.

Co-authorship network of co-authors of RenéS. Kahn

This figure shows the co-authorship network connecting the top 25 collaborators of RenéS. Kahn. A scholar is included among the top collaborators of RenéS. Kahn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RenéS. Kahn. RenéS. Kahn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Megen, Harold J.G.M. van, H.G.M. Westenberg, Johan A. den Boer, & RenéS. Kahn. (1996). Cholecystokinin in anxiety. European Neuropsychopharmacology. 6(4). 263–280. 97 indexed citations

Megen, Harold J.G.M. van, H.G.M. Westenberg, Johan A. den Boer, & RenéS. Kahn. (1996). The panic-inducing properties of the cholecystokinin tetrapeptide CCK4 in patients with panic disorder. European Neuropsychopharmacology. 6(3). 187–194. 53 indexed citations

Kahn, RenéS.. (1995). Schizophrenia, an integrated view. European Neuropsychopharmacology. 5(4). 535–535. 44 indexed citations

Kahn, RenéS., Michael Davidson, Larry J. Siever, Serge Sevy, & Kenneth L. Davis. (1994). Clozapine treatment and its effect on neuroendocrine responses induced by the serotonin agonist, m-chlorophenylpiperazine. Biological Psychiatry. 35(12). 909–912. 12 indexed citations

Stern, Robert G., RenéS. Kahn, Philip D. Harvey, et al.. (1993). Early response to haloperidol treatment in chronic schizophrenia. Schizophrenia Research. 10(2). 165–171. 31 indexed citations

Kahn, RenéS., et al.. (1993). Neuropsychological correlates of central monoamine function in schizophrenia. Schizophrenia Research. 9(2-3). 177–177. 1 indexed citations

Asnis, Gregory M., Scott Wetzler, William C. Sanderson, RenéS. Kahn, & H. M. van Praag. (1992). Functional interrelationship of serotonin and norepinephrine: Cortisol response to MCPP and DMI in patients with panic disorder, patients with depression, and normal control subjects. Psychiatry Research. 43(1). 65–76. 30 indexed citations

Kahn, RenéS. & H. M. van Praag. (1992). Panic disorder: a biological perspective. European Neuropsychopharmacology. 2(1). 1–20. 15 indexed citations

Kahn, RenéS., Larry J. Siever, Farooq Amin, et al.. (1992). Serotonin function in schizophrenia: Effects of meta- chlorophenylpiperazine in schizophrenia patients and healthy subjects. Psychiatry Research. 43(1). 1–12. 40 indexed citations

10.

Kahn, RenéS., et al.. (1992). Effect of m-Chlorophenylpiperazine on plasma homovanillic acid concentrations in healthy subjects. Biological Psychiatry. 32(11). 1055–1061. 9 indexed citations

11.

Kahn, RenéS., Scott Wetzler, Gregory M. Asnis, et al.. (1991). Pituitary hormone responses to meta-chlorophenylpiperazine in panic disorder and healthy control subjects. Psychiatry Research. 37(1). 25–34. 38 indexed citations

12.

Kahn, RenéS., Scott Wetzler, Gregory M. Asnis, Demitri F. Papolos, & H. M. van Praag. (1990). Serotonin receptor sensitivity in major depression. Biological Psychiatry. 28(4). 358–362. 37 indexed citations

13.

Kalus, Oren, RenéS. Kahn, Scott Wetzler, Gregory M. Asnis, & H. M. van Praag. (1990). Hypersensitivity to m-chlorophenylpiperazine in a subject with subclinical panic attacks. Biological Psychiatry. 28(12). 1053–1057. 16 indexed citations

14.

Kahn, RenéS. & H.G.M. Westenberg. (1985). L-5-Hydroxytryptophan in the treatment of anxiety disorders. Journal of Affective Disorders. 8(2). 197–200. 59 indexed citations

15.

Verhoeven, W.M.A., Jan M. van Ree, H.G.M. Westenberg, et al.. (1984). Clinical, biochemical, and hormonal aspects of treatment with des-tyr1-gamma-endorphin in schizophrenia. Psychiatry Research. 11(4). 329–346. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact